Intensive Care Units
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Coordination PharmaceuticalsIL - Chicago
1 programAutomatic lateralization therapyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
MaaT Pharmafecal microbiota transfer
Coordination PharmaceuticalsAutomatic lateralization therapy
Clinical Trials (2)
Total enrollment: 18 patients across 2 trials
Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY
Start: Jan 2018Est. completion: Feb 20198 patients
Phase 2Terminated
Immediate Effects of Automatic Lateralization in Critically Ill Patients
Start: Aug 2025Est. completion: Oct 202510 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.